HOST RESPONSES TO PHOTODYNAMIC THERAPY
宿主对光动力疗法的反应
基本信息
- 批准号:6269519
- 负责人:
- 金额:$ 21.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-04-01 至 1999-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The goal of this project remains to elucidate the complex mechanisms which
constitute the tissue response to photodynamic therapy (PDT). We have made
the novel observation that PDT alters the expression of IL-6 and IL-10
message and protein in treated tissues in vivo; thus we focus this renewal
application on the mechanisms and consequences of these effects. The
overall hypothesis are that PDT, via its oxidative stress mechanisms,
affects the transcriptional regulation of certain cytokines in vitro and
in vivo, that these effects differ for different photosensitizers,
depending on intracellular localizations, and that these changes in
cytokine expression affect host immune function at both the local and
systemic level. In Specific Aim 1 we will determine:(a) Whether PDT
induced alterations in cytokine gene expression depend on photosensitizer
type and localization. We expect to find photosensitizer (localization)-
dependent differences in the cytokine response similar to those described
for the PDT response of certain early response genes. (b) Whether PDT
affects IL-10 gene regulation directly and what molecular mechanisms are
involved. Based on our in vivo findings of IL-10 upregulation we expect to
find IL-10 gene regulation to be directly affected by PDT in at least some
of the cell types proposed for study. Since very little is known about IL-
10 gene regulation, this study will contribute to an overall understanding
of IL-10 gene control as well as to specific understanding of the effects
of PDT. In Specific Aim II we will determine whether the observed changes
in cytokine expression influence the local or systemic host immune
response, in particular the PDT-induced anti-tumor response and the PDT-
suppressed contact hypersensitivity (CHS) response. We will determine (a)
which cell types (especially in tumor and skin) secrete the cytokines of
interest following PDT in vivo; (b) the effect of PDT on immune cell
function at the tissue level, including antigen presentation and cytotoxic
and cytolytic immunogenicity; (d) and whether changes in cytokine
expression, especially IL-6 and IL-10, are involved in changes in immune
cell function. Since both IL-6 and IL-10 are important in anti-tumor and
CHS responses, it is expected that PDT induced changes in these cytokines
will affect the immune response in vivo. In Specific Aim III we will
determine whether the PDT induced changes in cytokine expression and
changes in inflammatory and immune cell infiltrates observed preclinically
also occur in patients. These studies have the long term goal of improving
the overall understanding of the effect of PDT on the immune system.
该项目的目标仍然是阐明复杂机制
构成对光动力疗法(PDT)的组织反应。我们做了
PDT改变了IL-6和IL-10的表达的新颖观察结果
在体内处理的组织中的消息和蛋白质;因此,我们集中于这个更新
应用这些影响的机制和后果。这
总体假设是PDT通过其氧化应激机制,
影响某些细胞因子在体外的转录调节,并且
在体内,这些效果在不同的光敏剂中有所不同,
取决于细胞内定位,并且这些变化
细胞因子表达会影响局部和
系统水平。在特定目标1中,我们将确定:(a)PDT是否
诱导的细胞因子基因表达的改变取决于光敏剂
类型和本地化。我们希望找到光敏剂(本地化) -
类似于描述的细胞因子反应的依赖性差异
对于某些早期反应基因的PDT响应。 (b)是否PDT
直接影响IL-10基因调节,哪些分子机制是
涉及。基于我们的体内IL-10上调的发现,我们期望
查找至少在某些中直接影响PDT的IL-10基因调节
提议研究的细胞类型。因为关于IL的知之甚少
10基因调节,这项研究将有助于整体理解
IL-10基因控制以及对影响的特定理解
PDT。在特定的目标II中,我们将确定观察到的变化是否变化
在细胞因子表达中影响局部或全身宿主免疫
响应,特别是PDT诱导的抗肿瘤反应和PDT-
抑制接触超敏反应(CHS)反应。我们将确定(a)
哪种细胞类型(尤其是在肿瘤和皮肤中)分泌的细胞因子
PDT在体内的兴趣; (b)PDT对免疫细胞的影响
组织水平的功能,包括抗原表现和细胞毒性
和细胞溶解免疫原性; (d)以及细胞因子的变化是否变化
表达,特别是IL-6和IL-10,与免疫变化有关
细胞功能。由于IL-6和IL-10都在抗肿瘤中很重要,并且
CHS响应,预计PDT会诱导这些细胞因子的变化
将影响体内免疫反应。在特定的目标III中,我们将
确定PDT是否诱导细胞因子表达和
观察到的炎症和免疫细胞浸润的变化
也发生在患者中。这些研究的长期目标是改善
PDT对免疫系统的影响的总体理解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BARBARA W. HENDERSON其他文献
BARBARA W. HENDERSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BARBARA W. HENDERSON', 18)}}的其他基金
PDT - Mechanisms and Strategies for Optimization
PDT - 优化机制和策略
- 批准号:
7561813 - 财政年份:1998
- 资助金额:
$ 21.42万 - 项目类别:
PDT - Mechanisms and Strategies for Optimization
PDT - 优化机制和策略
- 批准号:
8396569 - 财政年份:1998
- 资助金额:
$ 21.42万 - 项目类别:
PDT - Mechanisms and Strategies for Optimization
PDT - 优化机制和策略
- 批准号:
8034281 - 财政年份:1998
- 资助金额:
$ 21.42万 - 项目类别:
PDT - Mechanisms and Strategies for Optimization
PDT - 优化机制和策略
- 批准号:
8265735 - 财政年份:1998
- 资助金额:
$ 21.42万 - 项目类别:
PDT - Mechanisms and Strategies for Optimization
PDT - 优化机制和策略
- 批准号:
7760900 - 财政年份:1998
- 资助金额:
$ 21.42万 - 项目类别:
PDT - Mechanisms and Strategies for Optimization
PDT - 优化机制和策略
- 批准号:
8462208 - 财政年份:1998
- 资助金额:
$ 21.42万 - 项目类别:
PDT - Mechanisms and Strategies for Optimization
PDT - 优化机制和策略
- 批准号:
8230726 - 财政年份:1998
- 资助金额:
$ 21.42万 - 项目类别:
相似海外基金
Understanding vascular aging-related dementia through medin signaling
通过 medin 信号传导了解血管老化相关痴呆
- 批准号:
10901026 - 财政年份:2023
- 资助金额:
$ 21.42万 - 项目类别:
Elucidating anti-angiogenic tyrosine kinase inhibitor-induced vascular dysfunction
阐明抗血管生成酪氨酸激酶抑制剂诱导的血管功能障碍
- 批准号:
10570393 - 财政年份:2023
- 资助金额:
$ 21.42万 - 项目类别:
Them1 Inhibitors for the Management of Non-Alcoholic Fatty Liver Disease
Them1 治疗非酒精性脂肪肝的抑制剂
- 批准号:
10666090 - 财政年份:2023
- 资助金额:
$ 21.42万 - 项目类别:
Pharmacologic Contributors to Patent Ductus Arteriosus
动脉导管未闭的药理学贡献者
- 批准号:
10444540 - 财政年份:2022
- 资助金额:
$ 21.42万 - 项目类别:
A high-throughput screen for inhibitors of Plk1-interacting checkpoint helicase (PICH)
Plk1 相互作用检查点解旋酶 (PICH) 抑制剂的高通量筛选
- 批准号:
10356280 - 财政年份:2022
- 资助金额:
$ 21.42万 - 项目类别: